Antimony trioxide

CASRN 1309-64-4

  • IRIS Summary (PDF) (21 pp, 158 K)
  • Status: Antimony trioxide is not being reassessed by IRIS at this time.

Health Hazard Assessments for Effects Other than Cancer


Reference Dose for Oral Exposure (RfD) (PDF) (21 pp, 158 K)
Not assessed under the IRIS Program.

Reference Concentration for Inhalation Exposure (RfC) (PDF) (21 pp, 158 K) last updated: 09/01/1995

RfC (mg/m3) System Basis PoD Composite UF Confidence
2 x10-4 Respiratory Pulmonary toxicity, chronic interstitial inflammation BMC10 (HEC): 7.4 x10-2
mg/m3
300 Medium

Cancer Assessment


Weight of Evidence for Cancer (PDF) (21 pp, 158 K)
Not assessed under the IRIS Program.

Quantitative Estimate of Carcinogenic Risk from Oral Exposure (PDF) (21 pp, 158 K)

Not assessed under the IRIS Program.

Quantitative Estimate of Carcinogenic Risk from Inhalation Exposure (PDF) (21 pp, 158 K)

Not assessed under the IRIS Program.

You will need Adobe Reader to view some of the files on this page. See EPA’s PDF page to learn more.